DrugRisks cautions that patients should seek a lawyer with experience in this litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.
New York, NY (PRWEB) April 16, 2013
The birth control safety advocates at DrugRisks.com have added new information to the site for women using the contraceptives Yaz or Yasmin. Bayer recently informed investors and a federal court they will continue to settle blood clot claims plus as many as 10,000 claims alleging gallbladder injury.
The mission of DrugRisks is to give patients taking popular prescription drugs like Yaz and Yasmin the latest warnings, recalls, studies and legal news. With access to clear information, patients can discuss side effect concerns with their doctor and decide if they need legal advice.
Patients taking birth control pills have been cautioned by the British Medical Journal and FDA that those containing drospirenone, like Yaz and Yasmin, can increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%*.
Due to the number of patients filing a Yaz lawsuit alleging blood clot injuries, cases were consolidated to a special federal Multi-District Litigation court in Illinois. The case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois).
Bayer’s latest financial reports obtained by the resource center show the company has spent nearly $1 billion to settle around 4,800 claims alleging Yaz blood clots, and will continue to evaluate new claims for settlement on a case-by-case basis**.
Now, DrugRisks has learned that Bayer will also set aside a $24 million fund to settle as many as 10,000 claims alleging gallbladder injury***. However, these settlements are expected to pay only $2,000 to $3,000 before attorney’s fees and medical expenses, much less than for blood clots.
Lawyers are still helping those affected file a claim. Anyone who suffered a blood clot, DVT, stroke or pulmonary embolism after taking Yaz or Yasmin is urged to contact the DrugRisks Center or speak with a lawyer about their legal options.
Due to the specialized nature of federal MDL drug injury cases, DrugRisks cautions that patients should seek a lawyer with experience in this litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.
*British Medical Journal, October 25, 2011, University of Copenhagen; FDA, October 27, 2011, "Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints"
**Bayer 2012 Annual Report, Consolidated Financial Statement, Legal Notes, February 28, 2013